Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

Y-mAbs Announces Presentation of GD2-SADA Study at ASCO

Posted on May 26, 2023 By News Desk

NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that a poster presentation featuring the design of its Phase 1 clinical trial, evaluating the Company’s Self-Assembly DisAssembly Pre-targeted Radioimmunotherapy (“SADA Y-PRIT”) Theranostic Platform for the treatment of certain GD2-positive solid tumors, including small cell lung cancer, sarcoma and malignant melanoma will be presented at the American Society of Clinical Oncology (“ASCO”) Annual Meeting to be held June 2-6, 2023 in Chicago, Illinois.

Read more

Globe Newswire

Post navigation

Previous Post: Global Induction Furnace Market Revenue, Business Opportunities, Growth Trends And Forecast 2032 || Industry Key Players Are Electrotherm, Danieli & C. S.p.A, SMS Elotherm GmbH, Meltech Ltd., Tenova S.p.A
Next Post: Growing Demand for Second Phone Number App Market is projected to register an impressive CAGR, Upcoming Trends, Revenue, and Prominent Players By 2030

Archives

  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • Optometry Software Market Drivers, Opportunities, Challenges and Risks Factors Analysis by 2030
  • Fabric-Based Wearable Technology Market Research Insights with SWOT Analysis by Key Futuristic Trends, New Opportunities and Forecast to 2023-2030
  • Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
  • UV Infection Control Devices Market – Transforming healthcare environments with advanced UV technology
  • Biochemical Testing Service Market to Witness Massive Growth by 2029 | Merck, Ambipin, Nuohui Health

Copyright © 2023 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version